Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events

Titel Sort descending | Periode | Program | |
---|---|---|---|
International ekspansion med nyt produkt koncept | 2015 - 2016 | Innobooster
|
|
International ekspansion med nyt produkt koncept
Period
2015 - 2016
Region
Region Syddanmark Program
Innobooster Area
Ikke defineret Investment
Percentage
100 Invested
250.000 Budget
250.000 Partners
TRAVELMARKET A/S People
TRAVELMARKET A/S
Read more about the project
| |||
Internationalisering af DoseSystem 2.0 | 2017 - 2017 | Innobooster
|
|
Internationalisering af DoseSystem 2.0
Period
2017 - 2017
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
147.345 Budget
446.500 Partners
DoseSystem ApS People
DOSESYSTEM A/S
Read more about the project
| |||
Intertisement – Automatiseret tilpasning af 3D husmodeller til private husbyggeri m.m. | 2019 - 2019 | Innobooster
|
|
Intertisement – Automatiseret tilpasning af 3D husmodeller til private husbyggeri m.m.
Period
2019 - 2019
Region
Region Syddanmark Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
358.875 Budget
1.1 mill. Partners
Intertisement ApS People
INTERTISEMENT ApS
Read more about the project
| |||
Intestinal fibrosis sustains chronic inflammation for inflammatory bowel disease, through increased immune cell adhesion | 2023 - 2026 | Industrial Researcher
|
|
Intestinal fibrosis sustains chronic inflammation for inflammatory bowel disease, through increased immune cell adhesion
Period
2023 - 2026
Region
Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
43.93 Invested
1.1 mill. Budget
2.4 mill. Only around 33% of IBD patients will have a sustained response (primary responders) to biologics e.g. anti-TNFa. Intestinal fibrosis is believed to play a key role in IBD patients developing non-response to biologics. The overall goal of this project is to investigate how fibrosis regulates and affects inflammation, and how this is related to disease activity and treatment response. These results will hopefully give more insight into patient-tailored treatment as tool for precision medicine.
Partners
University of Southern Denmark, NORDIC BIOSCIENCE A/S People
Read more about the project
| |||
InTouch7 | 2020 - 2021 | Innobooster
|
|
InTouch7
Period
2020 - 2021
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
520.080 Budget
1.6 mill. Partners
Pellacon ApS People
Pellacon ApS
Read more about the project
| |||
Intra Oral Scanner - next generation | 2022 - 2023 | Innobooster
|
|
Intra Oral Scanner - next generation
Period
2022 - 2023
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
1.1 mill. Budget
3.0 mill. Partners
danBots People
Read more about the project
| |||
Introducing a FAS ligand hexameric (APO010) and companion diagnostics for the immunotherapy of Metastatic Breast Cancer | 2016 - 2019 | Industrial Researcher
|
|
Introducing a FAS ligand hexameric (APO010) and companion diagnostics for the immunotherapy of Metastatic Breast Cancer
Period
2016 - 2019
Region
Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
87.37 Invested
1.1 mill. Budget
1.2 mill. Partners
University of Copenhagen, Oncology Venture ApS People
Oncology Venture ApS
Read more about the project
| |||
INTRODUCING MEASLES-MUMPS-RUBELLA VACCINATION AT 6 MONTHS OF AGE: AN OPPORTUNITY T0 IMPROVE VACCINE COVERAGE, INCREASE CHILD HEALTH AND REDUCE THE COST OF INFECTIOUS CHILDHOOD DISEASES IN A HIGH-INCOME SETTING VACOP. Vaccine Advancement in | 2019 - 2023 | Grand Solutions
|
|
INTRODUCING MEASLES-MUMPS-RUBELLA VACCINATION AT 6 MONTHS OF AGE: AN OPPORTUNITY T0 IMPROVE VACCINE COVERAGE, INCREASE CHILD HEALTH AND REDUCE THE COST OF INFECTIOUS CHILDHOOD DISEASES IN A HIGH-INCOME SETTING VACOP. Vaccine Advancement in
Period
2019 - 2023
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
76.92 Invested
22.7 mill. Budget
29.5 mill. Partners
Copenhagen University Hospital (Rigshospitalet), Herlev Hospital, University of Copenhagen People
Region Hovedstaden
Read more about the project
| |||
Intuitivt trykprøvningsudstyr | 2022 - 2023 | Innobooster
|
|
Intuitivt trykprøvningsudstyr
Period
2022 - 2023
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
34.83 Invested
367.762 Budget
1.1 mill. Partners
LeakHunter ApS People
Read more about the project
| |||
Inuatek People | 2020 - 2021 | Innobooster
|
|
Inuatek People
Period
2020 - 2021
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
100 Invested
720.000 Budget
720.000 Partners
Inuatek A/S People
Inuatek A/S
Read more about the project
| |||
inVALUABLE (Insekt-værdikæde i en cirkulær bioøkonomi) | 2017 - 2020 | Grand Solutions
|
|
inVALUABLE (Insekt-værdikæde i en cirkulær bioøkonomi)
Period
2017 - 2020
Region
Region Hovedstaden Program
Grand Solutions Area
Bioressourcer, Fødevarer og Livsstil Investment
Percentage
76.45 Invested
19.0 mill. Budget
24.8 mill. Partners
Danish Technological Institute, Aarhus University, University of Copenhagen, Technical University of Denmark, Proti-Farm RnD BV, Novozymes A/S, Hannemann Engineering Aps, Ausumgaard I/S, ScrapTrans A/S, Agro Korn A/S, DryingMate A/S People
Teknologisk Institut
Read more about the project
| |||
Inventar i 100 pct. genanvendt og genanvendeligt plast til offentlige miljøer. | 2020 - 2021 | Innofounder
|
|
Inventar i 100 pct. genanvendt og genanvendeligt plast til offentlige miljøer.
Period
2020 - 2021
Region
Region Hovedstaden Program
Innofounder Area
Energi, Klima og Miljø Investment
Percentage
100 Invested
1.4 mill. Budget
1.4 mill. Partners
SMALLrevolution ApS People
SMALLrevolution ApS
Read more about the project
| |||
Investering og læring i én mobilapplikation | 2022 - 2023 | Innofounder
|
|
Investering og læring i én mobilapplikation
Period
2022 - 2023
Region
Region Hovedstaden Program
Innofounder Area
Ikke defineret Investment
Percentage
100 Invested
430.000 Budget
430.000 Partners
Astro.io ApS People
Astro.io ApS
Read more about the project
| |||
Investigate in vitro and in vivo differences between human, porcine and rodent islet function with respect to hypoxia, insulin resistance and proliferation. | 2015 - 2018 | Industrial Researcher
|
|
Investigate in vitro and in vivo differences between human, porcine and rodent islet function with respect to hypoxia, insulin resistance and proliferation.
Period
2015 - 2018
Region
Region Hovedstaden Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
50.62 Invested
1.0 mill. Budget
2.0 mill. Partners
University of Copenhagen, NOVO NORDISK A/S People
NOVO NORDISK A/S
Read more about the project
| |||
Investigating and measuring physical literacy and its health-related correlates in Danish children | 2019 - 2022 | Industrial Researcher
|
|
Investigating and measuring physical literacy and its health-related correlates in Danish children
Period
2019 - 2022
Region
Region Syddanmark Program
Erhvervsforsker Area
Handel, Service og Samfund Investment
Percentage
52.52 Invested
1.1 mill. Budget
2.0 mill. Partners
University of Copenhagen, DANSK SKOLEIDRÆT People
DANSK SKOLEIDRÆT
Read more about the project
|